Cerus Corporation
CERS
#7641
Rank
A$0.55 B
Marketcap
A$2.77
Share price
0.45%
Change (1 day)
31.75%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$16.52 Million, an increase over its 2023 earnings that were of -A$40.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-30.34%
2024 -A$16.52 Million-58.95%
2023 -A$40.24 Million-20.74%
2022 -A$50.76 Million-25.7%
2021 -A$68.32 Million-11.99%
2020 -A$77.63 Million-14%
2019 -A$90.26 Million21.73%
2018 -A$74.15 Million-0.65%
2017 -A$74.64 Million-10.96%
2016 -A$83.83 Million4.24%
2015 -A$80.42 Million50.99%
2014 -A$53.26 Million-10.08%
2013 -A$59.23 Million184.13%
2012 -A$20.85 Million-7.91%
2011 -A$22.64 Million
2009 -A$31.97 Million-24.69%
2008 -A$42.45 Million-25.2%
2007 -A$56.75 Million330.54%
2006 -A$13.19 Million1.49%
2005 -A$12.99 Million-61.02%
2004 -A$33.33 Million
2002 -A$82.42 Million10.02%
2001 -A$74.92 Million34.25%
2000 -A$55.81 Million61.02%
1999 -A$34.66 Million-18.81%
1998 -A$42.69 Million93.08%
1997 -A$22.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.70 B-46,873.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.32 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.34 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.2 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA